We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Novel POC Hemolysis System Improves Patient Care, Reduces Workload for Emergency Departments and ICUs

By HospiMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: Helge is a patented CE-marked concept for point of care hemolysis detection (Photo courtesy of Hemcheck Sweden)
Image: Helge is a patented CE-marked concept for point of care hemolysis detection (Photo courtesy of Hemcheck Sweden)

Hemolysis, or the rupturing of red blood cells, is the most common reason why a blood sample is deemed unfit for laboratory analysis. Every year, billions of blood samples are taken globally that are hemolyzed, while the majority of all medical decisions are based on results from blood test analysis. Missing or incorrect test results can lead to delayed treatment, spiraling healthcare costs, increased workloads for healthcare professionals and above all, unnecessary suffering for patients. For point of care analyses, such as blood gas analyses, results are released without checking for hemolysis. At the same time, there is scientific evidence that a large amount of blood samples are hemolysed and that hemolysis changes the analysis results for important analytes. For example, the analysis results may be falsely normal, while the actual values are completely different. This can lead to missing, incorrect or delayed care for patients with acute conditions. For some patient groups intravascular hemolysis is an important problem which can lead to adverse outcomes, and that needs to be detected and treated.

Now, an innovative product concept from Hemcheck Sweden AB (Solna, Sweden) enables the detection of hemolysed blood samples in direct connection with blood sampling near the patient, contributing to increased patient safety, more efficient processes and lower costs. Hemcheck operations are based around the Helge product concept. The product consists of three different disposable tests, v-Test for vacuum tubes and s-Test and bgs-Test for blood gas syringes, both of which can be used in the same reader.

For easy and user-friendly reading of disposable v-, bgs- and s-Tests, there is a common reader that, with a simple push of a button, signals if the blood sample is Hemolyzed or not. The aim is to identify hemolyzed blood samples at the time of sampling (point of care) and with the same quality as a laboratory. With an accessory screen connected to the reader, the user can determine the amount of free hemoglobin in the blood sample. The reader is mobile, easy to clean and can easily sit on a trolley or next to a blood gas analysis instrument. Today it can take up to one hour for a blood sample result to come back from the laboratory to the sampler. Helge performs the same analysis in a matter of seconds, opening up new possibilities for assessing blood sample quality and helping determining patient diagnosis.

Related Links:
Hemcheck Sweden AB 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
X-ray Diagnostic System
FDX Visionary-A
New
Hospital Bed
Alphalite

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.